186 related articles for article (PubMed ID: 37172786)
1. Targeting tumor endothelial cells with methyltransferase inhibitors: Mechanisms of action and the potential of combination therapy.
Zhou S; Ou H; Wu Y; Qi D; Pei X; Yu X; Hu X; Wu E
Pharmacol Ther; 2023 Jul; 247():108434. PubMed ID: 37172786
[TBL] [Abstract][Full Text] [Related]
2. DNA Methyltransferase Inhibitors and their Therapeutic Potential.
Zhou Z; Li HQ; Liu F
Curr Top Med Chem; 2018; 18(28):2448-2457. PubMed ID: 30465505
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of DNA Methylation.
Lopez M; Gilbert J; Contreras J; Halby L; Arimondo PB
Adv Exp Med Biol; 2022; 1389():471-513. PubMed ID: 36350520
[TBL] [Abstract][Full Text] [Related]
4. New insights on the mechanism of quinoline-based DNA Methyltransferase inhibitors.
Gros C; Fleury L; Nahoum V; Faux C; Valente S; Labella D; Cantagrel F; Rilova E; Bouhlel MA; David-Cordonnier MH; Dufau I; Ausseil F; Mai A; Mourey L; Lacroix L; Arimondo PB
J Biol Chem; 2015 Mar; 290(10):6293-302. PubMed ID: 25525263
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation inhibitors in cancer: recent and future approaches.
Gros C; Fahy J; Halby L; Dufau I; Erdmann A; Gregoire JM; Ausseil F; Vispé S; Arimondo PB
Biochimie; 2012 Nov; 94(11):2280-96. PubMed ID: 22967704
[TBL] [Abstract][Full Text] [Related]
6. DNA methyltransferases: emerging targets for the discovery of inhibitors as potent anticancer drugs.
Yu J; Xie T; Wang Z; Wang X; Zeng S; Kang Y; Hou T
Drug Discov Today; 2019 Dec; 24(12):2323-2331. PubMed ID: 31494187
[TBL] [Abstract][Full Text] [Related]
7. DNA Methyltransferase Inhibitors: Development and Applications.
Lopez M; Halby L; Arimondo PB
Adv Exp Med Biol; 2016; 945():431-473. PubMed ID: 27826847
[TBL] [Abstract][Full Text] [Related]
8. DNA methyltransferase-1 inhibitors as epigenetic therapy for cancer.
Singh V; Sharma P; Capalash N
Curr Cancer Drug Targets; 2013 May; 13(4):379-99. PubMed ID: 23517596
[TBL] [Abstract][Full Text] [Related]
9. DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application.
Hu C; Liu X; Zeng Y; Liu J; Wu F
Clin Epigenetics; 2021 Aug; 13(1):166. PubMed ID: 34452630
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic drug discovery: targeting DNA methyltransferases.
Foulks JM; Parnell KM; Nix RN; Chau S; Swierczek K; Saunders M; Wright K; Hendrickson TF; Ho KK; McCullar MV; Kanner SB
J Biomol Screen; 2012 Jan; 17(1):2-17. PubMed ID: 21965114
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel bacterial M.SssI DNA methyltransferase inhibitors.
Hupkes M; Azevedo R; Jansen H; van Zoelen EJ; Dechering KJ
J Biomol Screen; 2013 Mar; 18(3):348-55. PubMed ID: 23103529
[TBL] [Abstract][Full Text] [Related]
12. DNA methyltransferase inhibitors: an updated patent review (2012-2015).
Xu P; Hu G; Luo C; Liang Z
Expert Opin Ther Pat; 2016 Sep; 26(9):1017-30. PubMed ID: 27376512
[TBL] [Abstract][Full Text] [Related]
13. Targeting DNA methyltransferase in cancer.
Szyf M
Cancer Metastasis Rev; 1998 Jun; 17(2):219-31. PubMed ID: 9770119
[TBL] [Abstract][Full Text] [Related]
14. DNA Methylation Targeting: The DNMT/HMT Crosstalk Challenge.
Castillo-Aguilera O; Depreux P; Halby L; Arimondo PB; Goossens L
Biomolecules; 2017 Jan; 7(1):. PubMed ID: 28067760
[TBL] [Abstract][Full Text] [Related]
15. DNA methyltransferase inhibitors in cancer: a chemical and therapeutic patent overview and selected clinical studies.
Fahy J; Jeltsch A; Arimondo PB
Expert Opin Ther Pat; 2012 Dec; 22(12):1427-42. PubMed ID: 23033952
[TBL] [Abstract][Full Text] [Related]
16. De novo methyltransferases: Potential players in diseases and new directions for targeted therapy.
Saravanaraman P; Selvam M; Ashok C; Srijyothi L; Baluchamy S
Biochimie; 2020 Sep; 176():85-102. PubMed ID: 32659446
[TBL] [Abstract][Full Text] [Related]
17. DNA hypermethylation as a chemotherapy target.
Ren J; Singh BN; Huang Q; Li Z; Gao Y; Mishra P; Hwa YL; Li J; Dowdy SC; Jiang SW
Cell Signal; 2011 Jul; 23(7):1082-93. PubMed ID: 21345368
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of NSC 106084 and NSC 14778 and evaluation of their DNMT inhibitory activity.
Leroy M; Mélin L; LaPlante SR; Medina-Franco JL; Gagnon A
Bioorg Med Chem Lett; 2019 Mar; 29(6):826-831. PubMed ID: 30704813
[TBL] [Abstract][Full Text] [Related]
19. DNA methyltransferases in hematological malignancies.
Hoang NM; Rui L
J Genet Genomics; 2020 Jul; 47(7):361-372. PubMed ID: 32994141
[TBL] [Abstract][Full Text] [Related]
20. Human DNA (cytosine-5)-methyltransferases: a functional and structural perspective for epigenetic cancer therapy.
Rondelet G; Wouters J
Biochimie; 2017 Aug; 139():137-147. PubMed ID: 28600135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
